As of June 1, Dr. Kiran Turaga, a surgeon from the Medical College of Wisconsin, will be joining Dr. Hedy Kindler and the University of…
1717 K Street NW, Suite 900
Washington, DC 20006-5349
(877) 363-6376
HELPLINE
The Meso Foundation recently hosted a Meet the Mesothelioma Experts session with Dr. Raphael Bueno, the chief of thoracic surgery at Brigham and Women’s Hospital…
The Meso Foundation released a statement from its executive director, Mary Hesdorffer, APRN, about AstraZeneca’s tremelimumab trial for mesothelioma. In an AstraZeneca press release issued…
In the first of a special two-part series of Meet the Mesothelioma Experts, we interview our 2015 mesothelioma research grant recipients. In this session, we…
We are pleased to announce the funding of five new mesothelioma research projects by the Meso Foundation. To date the Meso Foundation has funded 99…
This week, we announced the release of a search tool which will enable users on the Meso Foundation’s website to easily search through nearly 100…
We have recently announced the 2016 dates for our International Symposium on Malignant Mesothelioma. In an effort to make it easier for the mesothelioma-affected community…
On October 14, the SELLAS Life Sciences Group, a biotech company leading a Phase 2 study of the WT1 vaccine, released the study’s promising data. The…
Last week, at the World Conference on Lung Cancer, Dr. Raffit Hassan presented promising data on a novel agent, anetumab ravtansine, also known as BAY…
If you attended our International Symposium on Malignant Mesothelioma in March of this year, you may recall the buzz of excitement that coursed throughout the…